Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (11)

2021

  1. Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community

    Neurologia, Vol. 36, Núm. 2, pp. 101-111

  2. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

    Neurobiology of Aging, Vol. 99, pp. 99.e15-99.e22

  3. Spanish expert consensus on the use of safinamide in Parkinson's disease

    Neurologia, Vol. 36, Núm. 9, pp. 666-672

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

  3. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

    Neurobiology of Aging, Vol. 87, pp. 139.e1-139.e7

2019

  1. Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation

    Journal of Parkinson's Disease, Vol. 9, Núm. 1, pp. 173-182

2012

  1. levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades

    Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688

2005

  1. Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination

    Neurologia, Vol. 20, Núm. 4, pp. 180-188

2004

  1. Nocturnal problems occurring in Parkinson's disease

    Neurology, Vol. 63, Núm. 8 SUPPL. 3

2003

  1. Treatment of Parkinson's disease in Spain

    Movement Disorders, Vol. 18, Núm. 1, pp. 87-89